Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents.
Zainaldin C, Arora S, Bathini S, Gupta U, Pandya V, Bae S, Worth S, Bachiashvili K, Bhatia R, Godby K, Jamy O, Rangaraju S, Diamond B, Oliver JD, Salzman D, Di Stasi A, Vachhani P. Zainaldin C, et al. Among authors: salzman d. Leuk Lymphoma. 2022 Dec;63(13):3245-3248. doi: 10.1080/10428194.2022.2113530. Epub 2022 Sep 15. Leuk Lymphoma. 2022. PMID: 36107006 No abstract available.
Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant.
Saad A, Taneja A, Di Stasi A, Sarmad R, Kukkamalla R, Costa L, Salzman D, Innis-Shelton R, Chewning JH, Meredith RF, Hauptfeld V, Langford S, Plessala K, Bhatia R, Lamb LS, Mineishi S. Saad A, et al. Among authors: salzman d. Bone Marrow Transplant. 2018 Oct;53(10):1345-1348. doi: 10.1038/s41409-018-0185-6. Epub 2018 May 4. Bone Marrow Transplant. 2018. PMID: 29728698 No abstract available.
Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2.
Holmqvist AS, Chen Y, Wu J, Kung M, Ness E, Parman M, Francisco L, Hageman L, Battles K, Bhatia R, Salzman D, Winther JF, Rosenthal J, Forman SJ, Weisdorf DJ, Armenian SH, Arora M, Bhatia S. Holmqvist AS, et al. Among authors: salzman d. Leukemia. 2018 Dec;32(12):2706-2709. doi: 10.1038/s41375-018-0171-4. Epub 2018 Jun 26. Leukemia. 2018. PMID: 29946190 Free PMC article. No abstract available.
Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation.
Jamy O, Innis-Shelton R, Bal S, Paluri R, Salzman D, Di Stasi A, Costa L, Meredith R, Lamb L, Minagawa K, Mineishi S, Saad A. Jamy O, et al. Among authors: salzman d. Am J Hematol. 2021 Oct 1;96(10):E396-E398. doi: 10.1002/ajh.26296. Epub 2021 Jul 31. Am J Hematol. 2021. PMID: 34288026 Free article. Clinical Trial. No abstract available.
Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia.
Arora S, Zainaldin C, Bathini S, Gupta U, Worth S, Bachiashvili K, Bhatia R, Godby K, Jamy O, Rangaraju S, Diamond B, Oliver JD, Salzman D, Di Stasi A, Vachhani P. Arora S, et al. Among authors: salzman d. Leuk Res. 2022 Jun;117:106844. doi: 10.1016/j.leukres.2022.106844. Epub 2022 Apr 25. Leuk Res. 2022. PMID: 35487134
Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study.
Armenian SH, Chen Y, Hageman L, Wu J, Landier W, Bosworth A, Francisco L, Schlichting E, Bhatia R, Salzman D, Wong FL, Weisdorf DJ, Forman SJ, Arora M, Bhatia S. Armenian SH, et al. Among authors: salzman d. J Clin Oncol. 2022 Oct 1;40(28):3278-3288. doi: 10.1200/JCO.21.02829. Epub 2022 Jun 22. J Clin Oncol. 2022. PMID: 35731989 Free PMC article.
90 results